Previous Close | 30.84 |
1-Year Change | 16.16% |
6-Months Change | -6.35% |
3-Months Change | 39.99% |
Moving Avg (50d) | 25.958 |
Moving Avg (200d) | 27.873 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 3.46B |
Beta (3-Years) | 1.09 |
Revenue Growth (ttm) | 46.99% |
Net Profit Margin (ttm) | -5.43% |
Return On Assets (ttm) | -3.64% |
EPS (ttm) | -1.02 |
PE Ratio (ttm) | -30.24 |
Dividend Yield | % |
Asset Description: | Evolent Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-07-25 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
30.223 | 29.298 | 28.681 | 27.756 | 26.214 | 24.672 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.